Nonmelanoma skin cancer risk awareness in azathioprine‐treated myasthenia gravis patients

OBJECTIVES: Increased rates of NMSC (nonmelanoma skin cancer) have recently been reported in people with MG (myasthenia gravis) receiving azathioprine treatment. Guidelines on azathioprine for patients with dermatological and gastrointestinal disorders stress the importance of NMSC risk awareness an...

Descripción completa

Detalles Bibliográficos
Autores principales: McGurgan, Iain J., McGuigan, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614050/
https://www.ncbi.nlm.nih.gov/pubmed/26516615
http://dx.doi.org/10.1002/brb3.396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614050/
https://www.ncbi.nlm.nih.gov/pubmed/26516615
http://dx.doi.org/10.1002/brb3.396

Ejemplares similares